MassMutual Small Cap Gr Eq R3 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
MassMutual Small Cap Growth Equity Fund Class R3 MSGNX
- NAV / 1-Day Return $4.89 / −1.41 %
- Fund Size $637.4M
- Adjusted Expense Ratio 1.550%
- Net Expense Ratio 1.580%
- Fee Level: Distribution High
- Share Class Type Retirement, Medium
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 76%
Morningstar’s Analysis MSGNX
Will MSGNX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 12.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Chord Energy Corp Ordinary Shares - New | 1.78 | 12M | Energy |
Protagonist Therapeutics Inc | 1.38 | 9M | Healthcare |
Xometry Inc Ordinary Shares - Class A | 1.34 | 9M | Industrials |
Fixed Inc Clearing Corp.Repo | 1.24 | 8M | Cash and Equivalents |
WisdomTree Inc | 1.19 | 8M | Financial Services |
Ligand Pharmaceuticals Inc | 1.18 | 8M | Healthcare |
Applied Industrial Technologies Inc | 1.07 | 7M | Industrials |
Viavi Solutions Inc | 1.05 | 7M | Technology |
SiTime Corp Ordinary Shares | 1.03 | 7M | Technology |
Twist Bioscience Corp | 1.02 | 7M | Healthcare |